Compare American Well Corp (AMWL) vs Banco Bilbao Vizcaya Argentaria SA (BBVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Banco Bilbao Vizcaya Argentaria SA — how do they compare? American Well Corp trades at $13.01 (market cap $220.94M), while Banco Bilbao Vizcaya Argentaria SA trades at $28.62 (market cap $157.51B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 712.9× American Well Corp's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | BBVA | |
|---|---|---|
Market Cap | $220.94M | $157.51B |
Sector | Health | Financials |
52-Week High | $13.58 | $28.50 |
52-Week Low | $3.78 | $17.96 |
Enterprise Value | $27.98M | — |
Dividend Yield | — | 3.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $12.54, down 7.66% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows improving financial trends, with revenue declining to $249.33M in 2025 but net losses narrowing significantly to -$95.70M. Recent Q2 2026 earnings beat expectations, and news highlights strategic developments including a key executive appointment at Amazon's healthcare unit.
The outlook suggests cautious optimism as AMWL progresses toward cash-flow breakeven, supported by analyst coverage leaning Hold. Key risks include persistent revenue declines and high cash burn, though improving margins and reduced losses indicate potential for recovery if execution continues.
BBVA trades at $28.545, up 0.69% today, with a bullish technical signal from moving averages but overbought RSI readings. The bank reported strong Q2 2026 earnings, beating estimates with an 11.4% net profit rise, and announced a $2.3 billion share buyback. Revenue growth has been steady, reaching $39.42 billion in 2025, with a net income margin of 26.13% and ROE of 18.5%, though valuation ratios like P/E of 12.98 and P/S of 3.27 suggest moderate pricing.
Outlook remains positive with analyst consensus at 53.85% buy ratings, driven by profitability improvements and strategic initiatives. Key risks include regulatory probes in Spain and antitrust investigations, which could impact sentiment. Investors should weigh solid fundamentals against legal uncertainties for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →
